167 related articles for article (PubMed ID: 30519891)
1. Spray Dried Smectite Clay Particles as a Novel Treatment against Obesity.
Dening TJ; Joyce P; Kovalainen M; Gustafsson H; Prestidge CA
Pharm Res; 2018 Dec; 36(1):21. PubMed ID: 30519891
[TBL] [Abstract][Full Text] [Related]
2. Inorganic surface chemistry and nanostructure controls lipolytic product speciation and partitioning during the digestion of inorganic-lipid hybrid particles.
Dening TJ; Joyce P; Webber JL; Beattie DA; Prestidge CA
J Colloid Interface Sci; 2018 Dec; 532():666-679. PubMed ID: 30121519
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured clay particles supplement orlistat action in inhibiting lipid digestion: An in vitro evaluation for the treatment of obesity.
Joyce P; Dening TJ; Meola TR; Gustafsson H; Kovalainen M; Prestidge CA
Eur J Pharm Sci; 2019 Jul; 135():1-11. PubMed ID: 31067495
[TBL] [Abstract][Full Text] [Related]
4. Contrasting Anti-obesity Effects of Smectite Clays and Mesoporous Silica in Sprague-Dawley Rats.
Joyce P; Dening TJ; Meola TR; Wignall A; Ulmefors H; Kovalainen M; Prestidge CA
ACS Appl Bio Mater; 2020 Nov; 3(11):7779-7788. PubMed ID: 35019518
[TBL] [Abstract][Full Text] [Related]
5. Montmorillonite and Laponite Clay Materials for the Solidification of Lipid-Based Formulations for the Basic Drug Blonanserin: In Vitro and in Vivo Investigations.
Dening TJ; Thomas N; Rao S; van Looveren C; Cuyckens F; Holm R; Prestidge CA
Mol Pharm; 2018 Sep; 15(9):4148-4160. PubMed ID: 30067372
[TBL] [Abstract][Full Text] [Related]
6. Nanostructured Montmorillonite Clay for Controlling the Lipase-Mediated Digestion of Medium Chain Triglycerides.
Dening TJ; Joyce P; Rao S; Thomas N; Prestidge CA
ACS Appl Mater Interfaces; 2016 Dec; 8(48):32732-32742. PubMed ID: 27934188
[TBL] [Abstract][Full Text] [Related]
7. Improving Correlations Between Drug Solubilization and In Vitro Lipolysis by Monitoring the Phase Partitioning of Lipolytic Species for Lipid-Based Formulations.
Dening TJ; Joyce P; Prestidge CA
J Pharm Sci; 2019 Jan; 108(1):295-304. PubMed ID: 30257194
[TBL] [Abstract][Full Text] [Related]
8. Carrier particle mediated stabilization and isolation of valsartan nanoparticles.
Kumar A; Davern P; Hodnett BK; Hudson SP
Colloids Surf B Biointerfaces; 2019 Mar; 175():554-563. PubMed ID: 30579056
[TBL] [Abstract][Full Text] [Related]
9. Sepiolite Clay Attenuates the Development of Hypercholesterolemia and Obesity in Mice Fed a High-Fat High-Cholesterol Diet.
Gutman R; Rauch M; Neuman A; Khamaisi H; Jonas-Levi A; Konovalova Y; Rytwo G
J Med Food; 2020 Mar; 23(3):289-296. PubMed ID: 31580748
[TBL] [Abstract][Full Text] [Related]
10. Preventive obesity agent montmorillonite adsorbs dietary lipids and enhances lipid excretion from the digestive tract.
Xu P; Dai S; Wang J; Zhang J; Liu J; Wang F; Zhai Y
Sci Rep; 2016 Feb; 6():19659. PubMed ID: 26891902
[TBL] [Abstract][Full Text] [Related]
11. Controlling the enzymatic digestion of lipids using hybrid nanostructured materials.
Tan A; Colliat-Dangus P; Whitby CP; Prestidge CA
ACS Appl Mater Interfaces; 2014 Sep; 6(17):15363-71. PubMed ID: 25116477
[TBL] [Abstract][Full Text] [Related]
12. Clay as a matrix former for spray drying of drug nanosuspensions.
Dong Y; Ng WK; Hu J; Shen S; Tan RB
Int J Pharm; 2014 Apr; 465(1-2):83-9. PubMed ID: 24560641
[TBL] [Abstract][Full Text] [Related]
13. Adsorptive property of Cu2+-ZnO/cetylpyridinium-montmorillonite complexes for pathogenic bacterium in vitro.
Ma YL; Yang B; Xie L
Colloids Surf B Biointerfaces; 2010 Sep; 79(2):390-6. PubMed ID: 20554164
[TBL] [Abstract][Full Text] [Related]
14. Internally structured pickering emulsions stabilized by clay mineral particles.
Guillot S; Bergaya F; de Azevedo C; Warmont F; Tranchant JF
J Colloid Interface Sci; 2009 May; 333(2):563-9. PubMed ID: 19243784
[TBL] [Abstract][Full Text] [Related]
15. Montmorillonite-lipid hybrid carriers for ionizable and neutral poorly water-soluble drugs: Formulation, characterization and in vitro lipolysis studies.
Dening TJ; Rao S; Thomas N; Prestidge CA
Int J Pharm; 2017 Jun; 526(1-2):95-105. PubMed ID: 28456653
[TBL] [Abstract][Full Text] [Related]
16. Long-term administration of an aqueous extract of dried, immature fruit of Poncirus trifoliata (L.) Raf. suppresses body weight gain in rats.
Shim WS; Back H; Seo EK; Lee HT; Shim CK
J Ethnopharmacol; 2009 Nov; 126(2):294-9. PubMed ID: 19703543
[TBL] [Abstract][Full Text] [Related]
17. Aripiprazole-montmorillonite: a new organic-inorganic nanohybrid material for biomedical applications.
Oh YJ; Choi G; Choy YB; Park JW; Park JH; Lee HJ; Yoon YJ; Chang HC; Choy JH
Chemistry; 2013 Apr; 19(15):4869-75. PubMed ID: 23436433
[TBL] [Abstract][Full Text] [Related]
18. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
19. Modification of the zeta potential of montmorillonite to achieve high active pharmaceutical ingredient nanoparticle loading and stabilization with optimum dissolution properties.
Kumar A; Hodnett BK; Hudson S; Davern P
Colloids Surf B Biointerfaces; 2020 Sep; 193():111120. PubMed ID: 32505995
[TBL] [Abstract][Full Text] [Related]
20. Desorption of intrinsic cesium from smectite: inhibitive effects of clay particle organization on cesium desorption.
Fukushi K; Sakai H; Itono T; Tamura A; Arai S
Environ Sci Technol; 2014 Sep; 48(18):10743-9. PubMed ID: 25144123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
